Related Experiment Videos
Prostate cancer in the older man
1Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Oncology (Williston Park, N.Y.)
|October 9, 2001
Summary
Prostate cancer diagnosis and treatment present unique challenges for older men. While screening benefits are debated, newer therapies like brachytherapy are used, and chemotherapy is well-tolerated in this age group.
Area of Science:
- Geriatric Oncology
- Urologic Oncology
- Cancer Epidemiology
Background:
- Prostate cancer predominantly affects men over 65.
- Older men face distinct challenges in prostate cancer management compared to younger patients.
Purpose of the Study:
- To review the specific issues in diagnosis, prevention, and treatment of prostate cancer in elderly men.
- To evaluate the implications of screening, treatment modalities, and side effects in older populations.
Main Methods:
- Review of existing literature and studies on prostate cancer in older men.
- Analysis of outcomes related to prostate-specific antigen (PSA) screening, radical prostatectomy, watchful waiting, brachytherapy, and chemotherapy.
Main Results:
- Prostate-specific antigen (PSA) screening's benefits may not outweigh risks to quality of life in older men.
- Some patients with rising PSA post-surgery have a favorable course, but watchful waiting is linked to higher mortality.
- Brachytherapy is increasingly used in older men despite limited comparative trial data.
- Older men may experience more morbidity from long-term testosterone suppression than younger patients.
- Chemotherapy is generally well-tolerated in older prostate cancer patients.
Conclusions:
- Prostate cancer management in older men requires careful consideration of individual health status and quality of life.
- Evidence is needed to guide optimal treatment choices, especially for newer therapies like brachytherapy.
- Further research should focus on the long-term effects and comparative efficacy of different treatment strategies in the elderly.